MedTrace Logo

Clinical Evaluation of Splendor X for Hair Removal

NCT04152707 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2021-07-02

No results posted yet for this study

Summary

At least 40 healthy male or female subjects that wish to remove their hair will be enrolled to this study.

Each subject will receive five treatments at 6-8 weeks intervals. Subjects will return for follow-up visits at 3, 6, 9, and 12 months after the last treatment.

Conditions

  • Hair Remval

Interventions

DEVICE

Splendor X

The Splendor X has two wavelengths in one system: Nd:YAG (1064nm) and Alexandrite (755nm).

Sponsors & Collaborators

  • Lumenis Be Ltd.

    lead INDUSTRY

Principal Investigators

  • Thomas Rohrer, Dr. · SkinCare Physicians

  • Anne Chapas, Dr. · Union Square Laser Dermatology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-08
Primary Completion
2023-03-31
Completion
2023-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04152707 on ClinicalTrials.gov